Anti-IGLK antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | IGLK |
| Immunogen: | KLH conjugated synthetic peptide derived from human IGLK 101-200/465 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:800-1:2000) |
| Reactivity: | Mouse, Rat,Chicken, Dog, Pig, Cow, Horse, Rabbit and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | ATP:D-hexose 6 phosphotransferase |
| FGQTL3 | |
| GCK | |
| GK | |
| GLK | |
| Glucokinase | |
| Hexokinase D | |
| Hexokinase D, pancreatic isozyme | |
| Hexokinase type IV | |
| Hexokinase-4 | |
| Hexokinase-D | |
| HHF3 | |
| HK IV | |
| HK4 | |
| HXK4_HUMAN | |
| HXKP | |
| LGLK |
Show More
Target information
Catalyzes the initial step in utilization of glucose by the beta-cell and liver at physiological glucose concentration. Glucokinase has a high Km for glucose, and so it is effective only when glucose is abundant. The role of GCK is to provide G6P for the synthesis of glycogen. Pancreatic glucokinase plays an important role in modulating insulin secretion. Hepatic glucokinase helps to facilitate the uptake and conversion of glucose by acting as an insulin-sensitive determinant of hepatic glucose usage.
Provider
Erpantech Laboratory
